Previous 10 | Next 10 |
home / stock / rna / rna articles
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quar...
Monday, Avidity Biosciences Inc (NASDAQ:RNA) revealed new long-term AOC 1001 data from the MARINA open-label extension (MARINA-OLE) trial...
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ: TSLA) fell during Monday&rsqu...
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Shares of Hormel Foods Corporation (NYSE: HRL) rose sharp...
As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in t...
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million publ...
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday. Shares of PDD Holdings Inc. (NASDAQ: PDD) shares jumped in Tuesd...
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 10 points on Tuesday. Following the market opening Tuesday, the Dow ...
Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NY...
News, Short Squeeze, Breakout and More Instantly...
Avidity Biosciences Inc. Company Name:
RNA Stock Symbol:
NASDAQ Market:
Avidity Biosciences Inc. Website:
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.68% on the day to $40.18. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
2024-06-24 08:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day PR Newswire FSHD Society to host Avidity webinar on positive initial data from the Phase 1/2 FORTITUDE™ trial for people living with FS...